Norheim / Winnipeg / Montreal / Ottawa / Vancouver / Jenkintown / Toronto / St. Louis / Rockville / Halifax / Tampa / London / /
Company
Sudbury / Novartis Pharmaceuticals Canada / Grossman AB / Jensen RT. / Canadian National Carcinoid Expert Group / Mark Evers / Nordic NE Tumour Group / Mallinckrodt / Girish BV / Novartis Pharmaceuticals Corporation / Surgical / /
Continent
Europe / /
Country
Canada / United Kingdom / United States / / /
Facility
Hospital St-Luc / University Health Network / Hospital Regional Cancer Centre / Royal Victoria Hospital / Boniface General Hospital / Princess Margaret Hospital / Queen Elizabeth II Health Sciences Centre / Vancouver Cancer Centre / Sandostatin LAR Depot / Women’s College Health Sciences Centre / Lee Moffitt Cancer Centre / Sudbury Regional Hospital / London Regional Cancer Centre / London Health Sciences Centre / Victoria Campus / Ottawa Hospital Regional Cancer Centre / /
IndustryTerm
Functional imaging / chemical response / imaging / chemical structures / radionuclide imaging / treatment of patients with carcinoid heart disease / conventional imaging / /
Royal Victoria Hospital / World Health Organization / Health Sciences Centre / B.C. Cancer Agency / Octreotide administration / Boniface General Hospital / European Neuroendocrine Tumour Society / Yale / Sudbury Regional Hospital / H. Lee Moffitt Cancer Centre / Princess Margaret Hospital / Sunnybrook and Women’s College Health Sciences Centre / Ottawa Hospital Regional Cancer Centre / Vancouver Cancer Centre / London Regional Cancer Centre / /
Person
L. Kvols / G. Bjarnason / Ann Oncol / A. Shah / L. Siu / Ann Clin Biochem / E. Chen / W. Kocha / J. Rivera / D. Rayson / S. Hanna / R. Reid / A. Roy / R. Wong / P. Poitras / C. Germond / /